Diagnostic and Interventional Cardiology

Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with Pfizer to support the validation and FDA clearance of its AI-based technology for the detection of cardiac amyloidosis.

News | Artificial Intelligence

Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

January 15, 2024 — Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the ...

January 15, 2024

Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology.

News | Stroke

Goldstein Selected to Help Lead Statewide Task Force Addressing Heart Disease and Stroke

January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected ...

January 15, 2024

Webinar addresses driving efficiency while maintaining diagnostic performance.

News | Computed Tomography (CT)

SPONSORED CONTENT: Webinar on Applying SMART-CT Results to Daily Clinical Practice

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

January 15, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality (ACM) and frequency of cardiovascular-related hospitalization (CVH)), with a Win Ratio of 1.8 (p<0.0001)

News | Pharmaceuticals

BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine

January 12, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

January 12, 2024

An unprecedented collaboration between an eminent heart surgeon, a Michelin-starred chef and a global cardiovascular device provider sees the launch of a unique, surgically inspired recipe book, conceived to help surgeons practice their surgical dexterity in an unexpected way

News | Cardiovascular Business

A World-first Collaboration to Help Heart Surgeons Utilize Their Dexterity in an Unexpected Way – Introducing The Heart Surgeon’s Cookbook

January 12, 2024 — The Heart Surgeon’s Cookbook is the brainchild of New York-based Cardiovascular and Thoracic Surgeon ...

January 12, 2024

News | Contrast Media Injectors

WEBINAR NOW AVAILABLE ON DEMAND: Contrast Management in Modern PCI

On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." ...

January 11, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of Bruce Wilkoff, MD, FHRS

News | EP Lab

In Memoriam: Bruce Wilkoff, MD, FHRS

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

January 11, 2024

The Journal of Lung and Heart Transplantation (JHLT) has published a real-world study indicating a significant reduction in Primary Graft Dysfunction (PGD), a severe post-transplant complication ― potentially allowing for an increase in donor hearts available for heart transplant patients

News | Cardiovascular Surgery

Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study

January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication ...

January 11, 2024

The cumulative incidence of MACE and all- cause of mortality in COVID-19 and non-COVID-19 pneumonia groups.

News | Coronavirus (COVID-19)

Chung-Ang University Study Looks at Cardiovascular Risks in COVID-19 Survivors

January 11, 2024 — Acute cardiovascular manifestations of COVID-19, such as heart failure, thrombosis, and dysrhythmia ...

January 11, 2024

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

82-year-old man with calcified stenosis in left main artery who underwent coronary CTA by PCD CT

News | CT Angiography (CTA)

Photon-Counting Detector CT Virtual Monoenergetic Images for Coronary Artery Stenosis Open configuration options

January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with ...

January 11, 2024

The roundtable focused on the current challenges in diagnosing and treating lower extremity revascularization, knowledge and data gaps, and the potential role of IVUS in addressing these challenges

News | Interventional Radiology

SCAI, SIR, and SVS Jointly Publish Proceedings from Multispecialty Peripheral IVUS Roundtable

January 9, 2024 — Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ...

January 09, 2024

New research from Mayo Clinic suggests that AI could improve the diagnosis of peripartum cardiomyopathy

News | Artificial Intelligence

Clinical Research Shows AI-enabled Digital Stethoscope can Detect Pregnancy-related Heart Disease

January 9, 2024 — New research from Mayo Clinic suggests that artificial intelligence (AI) could improve the diagnosis ...

January 09, 2024

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

FDA cleared, evidence-based AI and machine learning-based algorithm detects heart disease-associated ischemia

News | Artificial Intelligence

Cleerly Launches Cleerly ISCHEMIA Solution for Heart Disease Analysis

January 9, 2024 — Cleerly, the company working to create a new standard of care for the diagnosis of heart disease ...

January 09, 2024

Medtronic recently launched Penditure system for patients needing left atrial appendage closure

News | Left Atrial Appendage (LAA) Occluders

UH Harrington Heart and Vascular Institute First in World to Implant Penditure Clip Using Minimally Invasive Approach

January 8, 2024 — University Hospitals (UH) Harrington Heart & Vascular Institute recently became the first center in ...

January 08, 2024

News | Robotic Systems

Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter

January 8, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention ...

January 08, 2024